1
Published 2014
Canadian Agency for Drugs and Technologies in Health
... to neurology, from musculo-skeletal imaging to cardiology. PET has been used with success for the evaluation...

2
by Gray, Casey, Ford, Caitlyn
Published 2018
CADTH
... of Bobath therapy for treatment of patients with neurological conditions as well as to summarize evidence...

3
by Gray, Casey, Ford, Caitlyn
Published 2018
CADTH
... of Bobath therapy for treatment of patients with neurological conditions as well as to summarize evidence...

6
by Khangura, Sara, Visintini, Sarah
Published 2018
CADTH
...Off-label Use of IVIG for non-neurological paraneoplastic disorders...

7
by Khangura, Sara, Visintini, Sarah
Published 2018
CADTH
...Off-label Use of IVIG for non-neurological paraneoplastic disorders...

8
Published 2020
Canadian Agency for Drugs and Technologies in Health
... in patients three to 18 years of age with neurologic conditions associated with problem drooling...

9
Published 2020
Canadian Agency for Drugs and Technologies in Health
... to 18 years old with neurologic conditions associated with problem drooling (e.g., cerebral palsy...

10
by Ho, Chuong, Adcock, Lorna
Published 2018
CADTH
... of walking in patients with foot drop caused by various neurological conditions, but the effectiveness of FES...

11
by Ho, Chuong, Adcock, Lorna
Published 2018
CADTH
... of walking in patients with foot drop caused by various neurological conditions, but the effectiveness of FES...

12
Published 2013
Canadian Agency for Drugs and Technologies in Health
... hours of symptom onset, and it requires specific neurological expertise in order to guide the decision...

13
Published 2013
Canadian Agency for Drugs and Technologies in Health
... associated with 0.9% and 0.5% risk of transient and permanent neurologic deficits, respectively. Computed...

14
Published 2013
Canadian Agency for Drugs and Technologies in Health
... associated with 0.9% and 0.5% risk of transient and permanent neurologic deficits, respectively. Computed...

15
by Poitras, Veronica, Frey, Nina
Published 2017
Canadian Agency for Drugs and Technologies in Health
... hospital stay, who are undergoing surgery, or who have neurological deficits such as spinal cord injury...

16
by Poitras, Veronica, Frey, Nina
Published 2017
Canadian Agency for Drugs and Technologies in Health
... hospital stay, who are undergoing surgery, or who have neurological deficits such as spinal cord injury...

17
Published 2013
Canadian Agency for Drugs and Technologies in Health
... for OSA is polysomnography, a test that measures neurologic and cardio-respiratory parameters during sleep...

18
Published 2013
Canadian Agency for Drugs and Technologies in Health
... for OSA is polysomnography, a test that measures neurologic and cardio-respiratory parameters during sleep...

19
Published 2017
Canadian Agency for Drugs and Technologies in Health
... metabolism, which can be life-threatening and result in permanent neurological damage if left untreated....

20
Published 2017
Canadian Agency for Drugs and Technologies in Health
...Epilepsy is a chronic neurological disorder that manifests as a variety of seizure types...